CCL2 and pancreatic neoplasm: To confirm the increased population as TAMs, we sorted the CD11b + F4/80 + cells from the pancreatic tumors using a FACS sorter and quantified the expression of some TAM markers, such as HIF-1α, CCL2, and PECAM1, with qRT-PCR.